Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers
- Conditions
- Infant Development
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- ByHeart
- Target Recruit Count
- 2000
- Registration Number
- NCT05049655
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, LLC (Cohort 1), Birmingham, Alabama, United States
🇺🇸Watching Over Mothers & Babies (Cohort 1), Tuscan, Arizona, United States
🇺🇸The Children's Clinic of Jonesboro (Cohort 1), Jonesboro, Arkansas, United States
Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
- Conditions
- Term InfantsHealthy
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- ByHeart
- Target Recruit Count
- 311
- Registration Number
- NCT04389606
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, Birmingham, Alabama, United States
🇺🇸Watching Over Mothers and Babies, Tucson, Arizona, United States
🇺🇸The Children's Clinic of Jonesboro, P.A., Jonesboro, Arkansas, United States
Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
- Conditions
- InfantsNewborn
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- ByHeart
- Target Recruit Count
- 311
- Registration Number
- NCT04218929
- Locations
- 🇺🇸
Alabama Clinical Therapeutics, Birmingham, Alabama, United States
🇺🇸Watching Over Mothers and Babies, Tucson, Arizona, United States
🇺🇸The Children's Clinic of Jonesboro, P.A., Jonesboro, Arkansas, United States
News
ByHeart Secures $90M Series B Funding After Successful Infant Formula Clinical Trial
• ByHeart secured $90 million in Series B funding to launch its infant formula and advance its pipeline of mom and baby products. • The company's clinical trial with 311 babies met all endpoints, a key step for FDA submission and market entry. • ByHeart's trial included a breastfed reference arm, providing additional data to enhance infant nutrition science. • The funding will support ByHeart's mission to modernize infant nourishment with high-quality, transparent ingredients.